Connor, Clark & Lunn Investment Management »

Mineralys Therapeutics shares owned by Connor, Clark & Lunn Investment Management

Quarter-by-quarter ownership of Mineralys Therapeutics (MLYS) shares owned by Connor, Clark & Lunn Investment Management from 13F filings

Historical chart of Connor, Clark & Lunn Investment Management investment in Mineralys Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Mineralys Therapeutics held by Connor, Clark & Lunn Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mineralys Therapeutics by Connor, Clark & Lunn Investment Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $540k 14k 37.92

More positions owned by Connor, Clark & Lunn Investment Management

Rbc Cad (RY)
Agnico (AEM)
Shopify Cl A Sub Vtg Shs (SHOP)
Cibc Cad (CM)
Toronto Dominion Bk Ont Com New (TD)
NVIDIA Corporation (NVDA)
Invesco Exch Traded Fd Tr Ii Purbta Msci Us (PBUS)
Microsoft Corporation (MSFT)
Bk Nova Cad (BNS)
Apple (AAPL)
Tc Energy Corp (TRP)
Suncor Energy (SU)
Celestica (CLS)
Amazon (AMZN)
Enbridge (ENB)

View all positions for Connor, Clark & Lunn Investment Management

Top funds holding Mineralys Therapeutics

Catalys Pacific
RA Capital Management
Samsara BioCapital
BlackRock
Vanguard Group
Caligan Partners
Capital Research and Management Company - Division 3
Citadel Advisors
Suvretta Capital Management
Sr One Capital Management
FMR
Franklin Resources
Point72 Asset Management
Laurion Capital Management
Farallon Capital Management

View all funds holding Mineralys Therapeutics